Company intelligence / Profile preview

NutraShure

East Setauket, New York, USAnutrashure.com ↗

Ownership: Private
Development stage: Other

Overview

NutraShure has launched several branded nutraceutical ingredients with clinical and preclinical research backing. Their lead product BIOMEnd is a novel butyrate source designed for improved taste and solubility. The company is developing additional ingredients targeting metabolic balance and other wellness categories[3][4][5].

Therapeutic areas: Metabolic DisordersNeurologyPsychiatryDermatologyGastroenterologyOtherRheumatology
Modalities: Small molecule (e.g., butyrate, L-lysine-based compounds)Nutraceutical ingredientFunctional food ingredient
Industry: Food & Nutrition

Partnerships

Partners with various companies as an exclusive U.S. supplier of certain branded ingredients such as SA3X[7]Collaborates with other suppliers/distributors for innovation launches at industry events like SupplySide West[5]

Beyond the preview

Go deeper on NutraShure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NutraShure.

Explore the full profile